
Bio-Rad Laboratories, Inc.
BIONYSEHealthcareMedical - Devices
收盤時
US$381.76
+US$1.73 · +0.46%
盤後
US$388.93
+US$7.17 · +1.88%
8月24日 下午5:36 ET
BIO公司概覽
盤中時間採用ET。市場資料可能有所延遲。
GoAI 研究快照
簡明呈現最新可用的模型資訊。
GoAI評分
Hold
Wait — insufficient conviction to act
估值
64
Undervalued
動能
42
Neutral
情緒
66
Bullish
風險韌性
64
Moderate Risk
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
人工智慧產生的上下文僅供參考,並非投資建議。
公司概況
公司網站Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- 產業
- Medical - Devices
- 部門
- Healthcare
- 總部
- US
- 執行長
- Norman D. Schwartz
- 上市以來
- 1980年2月27日
- 僱員
- 7,450
市場位置
日內區間
目前US$381.76,
52週區間
目前US$381.76,
- 開盤價
- US$384.09
- 前收盤價
- US$380.03
- 成交量
- 0
- 0× 平均值
- 平均成交量
- 35.49萬
- 日均成交量
- 市值
- 102.76億 USD
- 貝塔
- 1.05
- 市場參考 1
- 50天平均值
- US$315.93
- 高於平均水平+20.84%
- 200天平均值
- US$298.24
- 高於平均水平+28.01%
財務數據
財務快照
最近十二個月估值與收益率
- 企業價值
- 92.6億 USD
- 本益比(TTM)
- 45.83×
- 股價淨值比(TTM)
- 1.42×
- 股價營收比(TTM)
- 3.97×
- EV/EBITDA
- 7.41×
- 盈餘收益率
- 9.20%
- 自由現金流收益率
- 4.53%
- 股息率
- 0.00%
獲利能力和效率
- 毛利率
- 51.90%
- 營業利益率
- 9.08%
- 淨利潤率
- 8.59%
- 股東權益報酬率
- 10.20%
- 資產報酬率
- 7.18%
- 投入資本報酬率
- 2.04%
財務健康
- 負債權益比
- 0.17×
- 流動比率
- 5.62×
財報歷史與展望
- EPS優於預期率
- 73%
- 優於預期8次、低於預期3次、符合預期0次
- 平均EPS意外幅度
- +21.92%
- 11 類似報告
- 最新每股收益結果
- 2.62
- 預估1.75 · 優於預期49.71%
EPS:實際值與預估值
近期已公布業績
營收:實際值與預估值
近期已公布業績
分析師評級
第三方分析師預期可能變動,並非 GoAI 建議。
評級分佈
14項評級BIO同業公司
持有BIO的ETF
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Mid-Cap ETFIJH2.21億0.17%1259.21億 USD0.05%US$76.20-0.74%
Vanguard Morningstar Total Stock Market ETFVTI1.91億0.01%2.3兆 USD0.03%US$377.07-0.31%
Vanguard Morningstar Small-Cap ETFVB1.38億0.07%1834億 USD0.03%US$302.9-0.61%
Vanguard Morningstar Small-Cap Value ETFVBR8765.83萬0.13%683億 USD0.05%US$248.44-0.30%
Vanguard Extended Market ETFVXF6750.75萬0.07%937億 USD0.05%US$243.43-0.86%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY5003.94萬0.19%267.17億 USD0.23%US$694.45-0.74%
Dimensional - US Small Cap Value ETFDFSV4535.62萬0.54%84.19億 USD0.30%US$40.04-0.62%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD3537.73萬0.19%187.69億 USD0.03%US$66.76-0.76%
iShares Core S&P Mid-Cap ETFIJH- 市場價值
- 2.21億
- 重量
- 0.17%
- AUM
- 1259.21億 USD
- 費用率
- 0.05%
- 價格 / 1日
- US$76.20-0.74%
Vanguard Morningstar Total Stock Market ETFVTI- 市場價值
- 1.91億
- 重量
- 0.01%
- AUM
- 2.3兆 USD
- 費用率
- 0.03%
- 價格 / 1日
- US$377.07-0.31%
Vanguard Morningstar Small-Cap ETFVB- 市場價值
- 1.38億
- 重量
- 0.07%
- AUM
- 1834億 USD
- 費用率
- 0.03%
- 價格 / 1日
- US$302.9-0.61%
Vanguard Morningstar Small-Cap Value ETFVBR- 市場價值
- 8765.83萬
- 重量
- 0.13%
- AUM
- 683億 USD
- 費用率
- 0.05%
- 價格 / 1日
- US$248.44-0.30%
Vanguard Extended Market ETFVXF- 市場價值
- 6750.75萬
- 重量
- 0.07%
- AUM
- 937億 USD
- 費用率
- 0.05%
- 價格 / 1日
- US$243.43-0.86%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY- 市場價值
- 5003.94萬
- 重量
- 0.19%
- AUM
- 267.17億 USD
- 費用率
- 0.23%
- 價格 / 1日
- US$694.45-0.74%
Dimensional - US Small Cap Value ETFDFSV- 市場價值
- 4535.62萬
- 重量
- 0.54%
- AUM
- 84.19億 USD
- 費用率
- 0.30%
- 價格 / 1日
- US$40.04-0.62%
State Street SPDR Portfolio S&P 400 Mid Cap ETFSPMD- 市場價值
- 3537.73萬
- 重量
- 0.19%
- AUM
- 187.69億 USD
- 費用率
- 0.03%
- 價格 / 1日
- US$66.76-0.76%
繼續GoAI的研究
在 GoAI 中研究BIOresearch.disclaimer





